In an in vivo xenograft model using a control and a MACC1 overexpressing cell line pair they found that MACC1 expression increased metastasis formation and this was reduced by selumetinib treatment.
The authors argue that MACC1 expression did not significantly influenced cell proliferation in the two cell line models.